HIV-1 resistance to dolutegravir is affected by cellular histone acetyltransferase activity.

about

The latest evidence for possible HIV-1 curative strategies.

P2860

Q52430553-B28632BD-E6F6-42C7-82A7-754471C4CAF9

P2860

HIV-1 resistance to dolutegravir is affected by cellular histone acetyltransferase activity.

Item

http://www.wikidata.org/entity/Q38637998

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

HIV-1 resistance to dolutegrav ...... ne acetyltransferase activity.

@en

type

Item

label

HIV-1 resistance to dolutegrav ...... ne acetyltransferase activity.

@en

prefLabel

HIV-1 resistance to dolutegrav ...... ne acetyltransferase activity.

@en

P1476

HIV-1 resistance to dolutegrav ...... ne acetyltransferase activity.

@en

P2093

Bluma Brenner

http://www.w3.org/2001/XMLSchema#string

Kaitlin Anstett

http://www.w3.org/2001/XMLSchema#string

Mark A Wainberg

http://www.w3.org/2001/XMLSchema#string

P2860

Acetylation of HIV-1 integrase by p300 regulates viral integration.

Acetylation of histones and transcription-related factors

Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

Structural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding Inhibitor

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study

Cryo-EM structures and atomic model of the HIV-1 strand transfer complex intasome

P31

scholarly article

P356

10.1128/JVI.00912-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thibault Mesplède

P577

2017-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28835492

http://www.w3.org/2001/XMLSchema#string

P932

5640858

http://www.w3.org/2001/XMLSchema#string

HIV-1 resistance to dolutegravir is affected by cellular histone acetyltransferase activity.

about

P2860

P2860

HIV-1 resistance to dolutegravir is affected by cellular histone acetyltransferase activity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932